[Generation and preliminary functional study of a CD133-2-harboring L929 cell line].

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi

Biotechnology Institute, Soochow University, Suzhou 215007, China.

Published: January 2010

AI Article Synopsis

  • The study aimed to create a modified L929 cell line that expresses the human CD133-2 gene and to examine its functional implications.
  • The CD133-2 gene was extracted from a foetal liver cDNA library, cloned into a vector, and transfected into L929 cells, which were then selectively cultured.
  • The results showed that the engineered cell line inhibits T cell proliferation and reduces activation markers, offering valuable insights into the role of CD133-2 in immune responses.

Article Abstract

Aim: To generate an engineered L929 cell line harboring human CD133-2 and perform the functional study of the gene-modified cell line.

Methods: The human CD133-2 gene was obtained by PCR from a cDNA library of foetus liver. After digested with Hind III and BamH I, the PCR product was cloned into pIRES2-EGFP vector. The recombinant plasmid CD133-2/pIRES2-EGFP was transfected into L929 cell line using lipofectamine, followed by G418 selection. RT-PCR, Western blot and flow cytometry (FCM) were used to detect the expression of CD133-2. MTT was used to analyze the effect of the CD133-2/L929 cells on proliferation of T cells. FCM was performed to monitor T cell activation by detecting T cell surface markers of CD4CD25 and CD8CD25 after T cells were cocultured with the CD133-2/L929 cells in the presence of an anti-CD3 mAb.

Results: A stable cell line constitutively expressing the human CD133-2 was established successfully. In the presence of the anti-CD3 mAb, CD133-2/L929 cells caused inhibition of T cell proliferation and down-regulation of the activation markers of CD4CD25 and CD8CD25 on T cells.

Conclusion: The engineered CD133-2/L929 cell line provides a gain-of-function cell model for further understanding the biological role of CD133-2.

Download full-text PDF

Source

Publication Analysis

Top Keywords

l929 cell
12
human cd133-2
12
cd133-2/l929 cells
12
cell
10
functional study
8
markers cd4cd25
8
cd4cd25 cd8cd25
8
presence anti-cd3
8
cd133-2
5
cells
5

Similar Publications

Purpose: During fixed orthodontic treatment, oral hygiene is difficult to ensure and can easily lead to an imbalance in the oral micro-ecological balance. In this study, based on the adhesive properties of polydopamine (PDA) and the good antimicrobial and remineralization properties of carboxymethyl chitosan (CMC) and xylitol (Xy), new nanocomposites with both antimicrobial and remineralization capabilities were prepared to coat on orthodontic brackets.

Methods: Composite carbon dots (CDs) were synthesized using carboxymethyl chitosan and xylitol, we characterized them and the antimicrobial properties of the CMC-Xy-CDs were investigated by co-cultivation with S.

View Article and Find Full Text PDF

In this study, Diels-Alder reaction was performed to sulfolene and endo/exo-diacetate compounds. After a series of reactions, new conduritol A and F analogs containing oxo-bridge and naphthalene rings in their structures were synthesized. To the starting compound, bromination, elimination, singlet oxygen reaction, acetylation, selective oxidation with osmium tetroxide (OsO), and m-chloroperbenzoic acid (m-CPBA), re-acetylation, and finally hydrolysis of the compounds by NH(g)/MeOH reactions were carried out.

View Article and Find Full Text PDF

Over the past decades, bacterial infections resulting from the misuse of antibiotics have garnered significant attention. Among the alternative antibacterial strategies, photodynamic therapy (PDT) has emerged as a promising non-antibiotic approach. However, persistent bacterial biofilms, particularly those composed of gram-negative bacteria with their protective outer membranes, have exhibited remarkable resilience to PDT.

View Article and Find Full Text PDF

Patients with severe eosinophilic asthma (SEA) can benefit from biologic therapy but some subjects may present an immune-mediated side effect. These patients will not meet the treatment goals and might have an increased risk of exacerbations. Monitoring these patients by determining blood eosinophil (BE) levels could be one of the tools that may allow a follow-up to prevent a worsening of asthma or exacerbations.

View Article and Find Full Text PDF

Adiponectin deficiency prevents chronic colitis-associated colonic fibrosis via inhibiting CXCL13 production.

J Adv Res

December 2024

Hebei Key Laboratory of Natural Products Activity Components and Function, Hebei Normal University of Science and Technology, Qinhuangdao, Hebei 066004, China. Electronic address:

Introduction: Colonic fibrosis is a long-term complication of inflammatory bowel disease (IBD), often leading to functional impairment, intestinal obstruction, and surgery. Adiponectin (APN) is an adipokine derived from adipocytes that plays a pleiotropic role in fibrosis regulation, depending on tissue and cell type specific or disease context, but its role in colonic fibrosis remains unclear.

Objective: To explore the role and involved mechanism of APN in chronic colitis-associated colonic fibrosis.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!